Navigation Links
A screening strategy using zebrafish targets genes that protect against hearing loss
Date:2/29/2008

A small striped fish is helping scientists understand what makes people susceptible to a common form of hearing loss, although, in this case, its not the fishs ears that are of interest. In a study published on February 29 in the open-access journal PLoS Genetics, researchers at the University of Washington have developed a research method that relies on a zebrafishs lateral linethe faint line running down each side of a fish that enables it to sense its surroundingsto quickly screen for genes and chemical compounds that protect against hearing loss from some medications. The study was funded in part by the National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health.

The fishs lateral line contains sensory cells that are functionally similar to those found in the inner ear, except these are on the surface of the fishs body, making them more easily accessible, said James F. Battey, Jr., M.D., Ph.D., director of the NIDCD. This means that scientists can very efficiently analyze the sensory structures under different conditions to find out what is likely to cause damage to these structures and, conversely, what can protect them from damage.

When people are exposed to some antibiotics and chemotherapy agents, the sensory structures in the inner ear, called hair cells, can be irreversibly damaged, resulting in hearing loss and balance problems. These are known as ototoxic medications. People vary widely in their susceptibility to these agents as well as to damage caused by other chemical agents, loud sounds and aging.

To find out why this is so, senior scientists Edwin Rubel, David Raible, and their research team developed a screening strategy that uses hair cells in the lateral line of zebrafish larvae to signal how hair cells in a persons inner ear might respond under similar conditions. Hair cells are named for small bristly extensions, or stereocilia, jutting from their tops. Mov
'/>"/>

Contact: Mary Kohut
Press@plos.org
415-568-3457
Public Library of Science
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UNC study questions FDA genetic-screening guidelines for cancer drug
2. MIT: Micro livers could aid drug screening
3. New screening strategy for detection of chagas disease in children
4. Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines
5. Embryonic stem cell strategy advanced with UCSF finding
6. Penn Veterinary Medicine report new strategy to create genetically-modified animals
7. Bee strategy helps servers run more sweetly
8. Lupus Research Institute strategy delivers $30 million in national funding
9. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough
10. Carbon capture strategy could lead to emission-free cars
11. Strategy for nanotechnology-related environmental, health and safety research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Using highly precise measurements of plasma lipop...ic resonance spectroscopy (NMR), researchers led b...nd Harvard Medical School in Boston, MA, the Frami... consortium in Stockholm, Sweden and Oxford, Engla...he whole genome among 17,296 women of European anc...
(Date:11/20/2009)... Researchers are invited to contribute their abstr...OF WCO ECCEO10), the largest global meeting devot...is research and patient care. The Congress will be...eginning today, abstracts can be submitted online ...sion deadline is February 4, 2010. , IOF and ESC...
(Date:11/20/2009)..., A key question in the origin of biological mol...ether billions of years ago from simple precursors...searchers in Italy have reconstructed one of the e...ains of RNA from individual subunits using nothing...t RNA was one of the first biological molecules pr...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 1National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 2National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 4Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 1Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 2Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 3Stryker Announces Election of New Director 53107 1Stryker Announces Election of New Director 53107 2
...uebec City, Canada - An international team of scie...iversity of Hull, Cardiff University) and Spain (D...pair of closely related species of East African ci...rising hundreds of species has puzzled evolutionar... gene adaptations which might explain why they do ...
...AINESVILLE, Fla. When the first four-legged animal...genetic recipe and simply extended the cooking tim... Wednesdays issue of the journal PLoS ONE. , Ev... billion years have the recipe for fingers in thei...hem. , While studying the mechanisms of developm...
...OSTONColon cancer patients who eat a diet high in ...erts a so-called Western diet may be increasing ...eport researchers at Dana-Farber Cancer Institute....he Journal of the American Medical Association, in...that has been treated with both surgery and chemot...
Other Biology News:Adaptation to parasites drive African fishes along different evolutionary paths 2Conquest of land began in shark genome 2Conquest of land began in shark genome 3'Western' diet linked to increased risk of colon cancer recurrence 2
(Date:11/19/2009)...Nov. 19 Dr. Mate Hidvegi, inventor...to a press release issued on November 17 by Biroph...aking false and self-serving statements about its ...idvegi stated from his office in Budapest, Hungary...emar does not apply to AveULTRA, www.aveultra.co...
(Date:11/19/2009)...9 NeoStem, Inc. (NYSE Am...ollowing letter to its shareholders, discussing th...hina Biopharmaceuticals Holdings, Inc. (CHBP), an ... People,s Republic of China. The merger gives NeoS...maceutical Co. Ltd., CHBP,s primary operating subs...
(Date:11/19/2009)... and WALTHAM, Mass., Nov. 19 Arlin...s find that the leading driver of antibiotic selec...ectrum activity against gram-positive and gram-neg...hat can cause nosocomial pneumonia, surveyed Europ... agents that provide appropriate coverage against ...
(Date:11/19/2009)...9 /PRNewswire/ - Aegera Therapeutics Inc. announce...mized Phase 2B study of AEG35156, a targeted antis...iple oncology indications. ,, The study, entitl...X-Linked Inhibitor of Apoptosis (XIAP) Antisense A...bine and Idarubicin in AML Following Failure of a ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
... May 11 Pharmasset, Inc. (Nasdaq: VRUS ), a cli...scovering, developing, and commercializing novel d... results and operational highlights for the fiscal...sults , , Revenues were $1.9 million during the ...ion for the quarter ended March 31, 2008 and refle...
...1, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: AR...t quarter ended March 31, 2009. , , Arena report...the first quarter of 2009 of $50.6 million, or $0....common stockholders in the first quarter of 2008 o...ing the positive lorcaserin BLOOM results was a si...
... joins the Digital Arts Alliance , , BATON ROUGE,...ed plans to support, for the second year in a row,...nsive Orientation for Students (BIOS) program with... class of Pearson Foundation Digital Arts Fellows ...es and pass them along to future program participa...
Other Biology Technology:Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 5Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 6Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 7Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 8Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 2Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 3Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 4Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 5Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 6Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 7Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 8Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 2Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 3
CLEARMOUNT from Invitrogen
...Polyclonal Antibody Production Conjugated pepti...abbits ten-week protocol to produce antibodies in...00-120 ml antiserum) ELISA test until the titer r...eaches target titer Protein G purification Antib...
3' RACE Adapter Primer from Invitrogen
Normal Goat Serum from Calbiochem
Biology Products: